Ibere Pharmaceuticals OverviewIbere Pharmaceuticals Operating Income
Operating Income for IBER.
Quarterly Operating Income
$-233604.00
↓ 25.96% YoY
As of Sep 30, 2022
Annual Operating Income (TTM)
$-1037159.00
Trailing 12 months ending Sep 30, 2022
Ibere Pharmaceuticals OverviewOperating Income for IBER.
As of Sep 30, 2022
Trailing 12 months ending Sep 30, 2022